Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker

RNA‐binding Motif Protein39 (RBM39) is identified as a splicing factor and transcription coactivator. Despite mounting evidence that RBM39 plays a critical role in the development of specific malignancies, no systematic pan‐cancer investigation of RBM39 has been conducted. As a result, we set out to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui, Wang, Wei, Zhang, Nie, Chen, Xueting, Liu, Wanming, Zhang, Longzhen, Liu, Nianli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465192/
https://www.ncbi.nlm.nih.gov/pubmed/35989423
http://dx.doi.org/10.1111/jcmm.17517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465192/
https://www.ncbi.nlm.nih.gov/pubmed/35989423
http://dx.doi.org/10.1111/jcmm.17517

Ejemplares similares